BIOXCEL THERAPEUTICS, INC. INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies BioXcel Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
18 juil. 2023 16h07 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, July 18, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of persons and entities that purchased or acquired securities...
BIOXCEL THERAPEUTICS, INC. (NASDAQ: BTAI) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioXcel Therapeutics, Inc.
18 juil. 2023 10h30 HE
|
Bernstein Liebhard LLP
NEW YORK, July 18, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities...
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BTAI
17 juil. 2023 20h15 HE
|
The Rosen Law Firm PA
NEW YORK, July 17, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) between December...
DEADLINE ALERT for IBRX, BTAI, and STX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
14 juil. 2023 23h06 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, July 14, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
BIOXCEL THERAPEUTICS, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against BioXcel Therapeutics, Inc. (NASDAQ: BTAI)
11 juil. 2023 01h45 HE
|
Bernstein Liebhard LLP
NEW YORK, July 11, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of BioXcel Therapeutics, Inc. (NASDAQ: BTAI)?Did you purchase your shares between December 15,...
BTAI Shareholder News: Johnson Fistel Encourages BioXcel Therapeutics Shareholders with Losses to Contact the Firm Regarding Investigation
29 juin 2023 10h48 HE
|
Johnson Fistel, LLP
SAN DIEGO, June 29, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether BioXcel Therapeutics (NASDAQ: BTAI), any of its...
BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021
28 juil. 2021 07h00 HE
|
BioXcel Therapeutics
NEW HAVEN, Conn., July 28, 2021 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (NASDAQ: BTAI), a clinical-stage biopharmaceutical company utilizing artificial...
BioXcel Therapeutics to Present at Canaccord Genuity 41st Annual Growth Conference
19 juil. 2021 07h30 HE
|
BioXcel Therapeutics
NEW HAVEN, Conn., July 19, 2021 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. ("BioXcel" or the "Company") (Nasdaq: BTAI), today announced that Dr. Vimal Mehta, Ph.D., Founder and Chief Executive...